CFTR suppresses tumor progression through miR-193b targeting urokinase plasminogen activator (uPA) i...
CFTR suppresses tumor progression through miR-193b targeting urokinase plasminogen activator (uPA) in prostate cancer
About this item
Full title
Author / Creator
Xie, C , Jiang, X H , Zhang, J T , Sun, T T , Dong, J D , Sanders, A J , Diao, R Y , Wang, Y , Fok, K L , Tsang, L L , Yu, M K , Zhang, X H , Chung, Y W , Ye, L , Zhao, M Y , Guo, J H , Xiao, Z J , Lan, H Y , Ng, C F , Lau, K M , Cai, Z M , Jiang, W G and Chan, H C
Publisher
London: Nature Publishing Group UK
Journal title
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
Cystic fibrosis (CF) transmembrane conductance regulator (CFTR) is expressed in the epithelial cells of a wide range of organs/tissues from which most cancers are derived. Although accumulating reports have indicated the association of cancer incidence with genetic variations in
CFTR
gene, the exact role of CFTR in cancer development and the...
Alternative Titles
Full title
CFTR suppresses tumor progression through miR-193b targeting urokinase plasminogen activator (uPA) in prostate cancer
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_1352289256
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1352289256
Other Identifiers
ISSN
0950-9232
E-ISSN
1476-5594
DOI
10.1038/onc.2012.251
